A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Genmab
Genmab
University Hospital Southampton NHS Foundation Trust
University of Miami
National Institutes of Health Clinical Center (CC)
Actuate Therapeutics Inc.
University of Nebraska
University of Birmingham
The First Affiliated Hospital with Nanjing Medical University
Medstar Health Research Institute
Universität des Saarlandes
University of Miami
Seagen Inc.
The First Affiliated Hospital with Nanjing Medical University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Southern California
University of Kentucky
Hoag Memorial Hospital Presbyterian
National Cancer Institute (NCI)
National Cancer Institute (NCI)
SWOG Cancer Research Network
Dana-Farber Cancer Institute
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health Clinical Center (CC)
Heidelberg University
St. Jude Children's Research Hospital